Prevalence and immunopathologic characteristics of seropositive and seronegative hepatitis B virus-associated membranous nephropathy: a retrospective study of 420 biopsy-proven cases

Background This retrospective study aims to investigate the prevalence and immunopathologic characteristics of seropositive and seronegative hepatitis B virus-associated membranous nephropathy (HBV-MN).Methods Clinicopathologic and serologic records of 420 patients with histologically confirmed HBV-...

Full description

Saved in:
Bibliographic Details
Main Authors: Haitao Lu, Qianqian Xu, Guming Zou, Hongmei Gao, Yue Yang, Wenge Li, Li Zhuo
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Renal Failure
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2024.2313180
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591075596828672
author Haitao Lu
Qianqian Xu
Guming Zou
Hongmei Gao
Yue Yang
Wenge Li
Li Zhuo
author_facet Haitao Lu
Qianqian Xu
Guming Zou
Hongmei Gao
Yue Yang
Wenge Li
Li Zhuo
author_sort Haitao Lu
collection DOAJ
description Background This retrospective study aims to investigate the prevalence and immunopathologic characteristics of seropositive and seronegative hepatitis B virus-associated membranous nephropathy (HBV-MN).Methods Clinicopathologic and serologic records of 420 patients with histologically confirmed HBV-MN between January 2014 and July 2021 were examined to determine the prevalence of seropositive and seronegative HBV-MN. Serum anti-PLA2R antibody testing was conducted on 280 patients with HBV-associated membranous nephropathy (HBV-MN) from August 2018 to July 2021. Immunopathologic characteristics of HBV-MN patients and anti-PLA2R antibody positivity were analyzed.Results Among 420 pathologically confirmed HBV-MN patients, 230 (54.8%) were seropositive for HBV. The seropositive group exhibited higher blood creatinine values and incidence of liver function abnormalities than the seronegative group (p < .05). Serum anti-PLA2R antibody testing on 280 HBV-MN patients revealed a total positive rate of 44.6%, with the seronegative group showing a significantly higher rate (62.6%) compared to the seropositive group (32.1%) (p < .01). The anti-PLA2R antibody-positive group displayed higher levels of urine protein (p < .05), serum cholesterol (p < .01), and IgG4 subtypes (p < .05) compared to the negative group. Additionally, the positive group had significantly lower levels of serum albumin and IgG than the negative group (p < .01).Conclusions This comprehensive study reveals a significantly higher prevalence of seronegative HBV-MN than previously thought. The blood creatinine values and incidence of liver function abnormalities was higher in the serology-positive group than in the serology-negative group. Notably, the seronegative group displayed a higher positive rate of anti-PLA2R antibodies compared to the seropositive group, indicating distinctive clinical and immunopathologic features.
format Article
id doaj-art-04d150c9cd9c457bbfb8db59639606c8
institution Kabale University
issn 0886-022X
1525-6049
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Renal Failure
spelling doaj-art-04d150c9cd9c457bbfb8db59639606c82025-01-23T04:17:49ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492024-12-0146110.1080/0886022X.2024.2313180Prevalence and immunopathologic characteristics of seropositive and seronegative hepatitis B virus-associated membranous nephropathy: a retrospective study of 420 biopsy-proven casesHaitao Lu0Qianqian Xu1Guming Zou2Hongmei Gao3Yue Yang4Wenge Li5Li Zhuo6Department of Nephrology, Friendship Hospital, Beijing, ChinaDepartment of Nephrology, Friendship Hospital, Beijing, ChinaDepartment of Nephrology, Friendship Hospital, Beijing, ChinaDepartment of Nephrology, Friendship Hospital, Beijing, ChinaDepartment of Nephrology, Friendship Hospital, Beijing, ChinaDepartment of Nephrology, Friendship Hospital, Beijing, ChinaDepartment of Nephrology, Friendship Hospital, Beijing, ChinaBackground This retrospective study aims to investigate the prevalence and immunopathologic characteristics of seropositive and seronegative hepatitis B virus-associated membranous nephropathy (HBV-MN).Methods Clinicopathologic and serologic records of 420 patients with histologically confirmed HBV-MN between January 2014 and July 2021 were examined to determine the prevalence of seropositive and seronegative HBV-MN. Serum anti-PLA2R antibody testing was conducted on 280 patients with HBV-associated membranous nephropathy (HBV-MN) from August 2018 to July 2021. Immunopathologic characteristics of HBV-MN patients and anti-PLA2R antibody positivity were analyzed.Results Among 420 pathologically confirmed HBV-MN patients, 230 (54.8%) were seropositive for HBV. The seropositive group exhibited higher blood creatinine values and incidence of liver function abnormalities than the seronegative group (p < .05). Serum anti-PLA2R antibody testing on 280 HBV-MN patients revealed a total positive rate of 44.6%, with the seronegative group showing a significantly higher rate (62.6%) compared to the seropositive group (32.1%) (p < .01). The anti-PLA2R antibody-positive group displayed higher levels of urine protein (p < .05), serum cholesterol (p < .01), and IgG4 subtypes (p < .05) compared to the negative group. Additionally, the positive group had significantly lower levels of serum albumin and IgG than the negative group (p < .01).Conclusions This comprehensive study reveals a significantly higher prevalence of seronegative HBV-MN than previously thought. The blood creatinine values and incidence of liver function abnormalities was higher in the serology-positive group than in the serology-negative group. Notably, the seronegative group displayed a higher positive rate of anti-PLA2R antibodies compared to the seropositive group, indicating distinctive clinical and immunopathologic features.https://www.tandfonline.com/doi/10.1080/0886022X.2024.2313180Hepatitis B virusHBV-associated membranous nephropathy (HBV-MN)seroprevalencemembranous nephropathy (MN)anti-phospholipase A2 receptor antibody
spellingShingle Haitao Lu
Qianqian Xu
Guming Zou
Hongmei Gao
Yue Yang
Wenge Li
Li Zhuo
Prevalence and immunopathologic characteristics of seropositive and seronegative hepatitis B virus-associated membranous nephropathy: a retrospective study of 420 biopsy-proven cases
Renal Failure
Hepatitis B virus
HBV-associated membranous nephropathy (HBV-MN)
seroprevalence
membranous nephropathy (MN)
anti-phospholipase A2 receptor antibody
title Prevalence and immunopathologic characteristics of seropositive and seronegative hepatitis B virus-associated membranous nephropathy: a retrospective study of 420 biopsy-proven cases
title_full Prevalence and immunopathologic characteristics of seropositive and seronegative hepatitis B virus-associated membranous nephropathy: a retrospective study of 420 biopsy-proven cases
title_fullStr Prevalence and immunopathologic characteristics of seropositive and seronegative hepatitis B virus-associated membranous nephropathy: a retrospective study of 420 biopsy-proven cases
title_full_unstemmed Prevalence and immunopathologic characteristics of seropositive and seronegative hepatitis B virus-associated membranous nephropathy: a retrospective study of 420 biopsy-proven cases
title_short Prevalence and immunopathologic characteristics of seropositive and seronegative hepatitis B virus-associated membranous nephropathy: a retrospective study of 420 biopsy-proven cases
title_sort prevalence and immunopathologic characteristics of seropositive and seronegative hepatitis b virus associated membranous nephropathy a retrospective study of 420 biopsy proven cases
topic Hepatitis B virus
HBV-associated membranous nephropathy (HBV-MN)
seroprevalence
membranous nephropathy (MN)
anti-phospholipase A2 receptor antibody
url https://www.tandfonline.com/doi/10.1080/0886022X.2024.2313180
work_keys_str_mv AT haitaolu prevalenceandimmunopathologiccharacteristicsofseropositiveandseronegativehepatitisbvirusassociatedmembranousnephropathyaretrospectivestudyof420biopsyprovencases
AT qianqianxu prevalenceandimmunopathologiccharacteristicsofseropositiveandseronegativehepatitisbvirusassociatedmembranousnephropathyaretrospectivestudyof420biopsyprovencases
AT gumingzou prevalenceandimmunopathologiccharacteristicsofseropositiveandseronegativehepatitisbvirusassociatedmembranousnephropathyaretrospectivestudyof420biopsyprovencases
AT hongmeigao prevalenceandimmunopathologiccharacteristicsofseropositiveandseronegativehepatitisbvirusassociatedmembranousnephropathyaretrospectivestudyof420biopsyprovencases
AT yueyang prevalenceandimmunopathologiccharacteristicsofseropositiveandseronegativehepatitisbvirusassociatedmembranousnephropathyaretrospectivestudyof420biopsyprovencases
AT wengeli prevalenceandimmunopathologiccharacteristicsofseropositiveandseronegativehepatitisbvirusassociatedmembranousnephropathyaretrospectivestudyof420biopsyprovencases
AT lizhuo prevalenceandimmunopathologiccharacteristicsofseropositiveandseronegativehepatitisbvirusassociatedmembranousnephropathyaretrospectivestudyof420biopsyprovencases